{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:53:32Z","timestamp":1789872812513,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jtho.2017.01.028","type":"journal-article","created":{"date-parts":[[2017,2,5]],"date-time":"2017-02-05T02:19:34Z","timestamp":1486261174000},"page":"860-871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Loss of p16 INK4A Expression and Homozygous CDKN2A Deletion Are Associated with Worse Outcome and Younger Age in Thymic Carcinomas"],"prefix":"10.1016","volume":"12","author":[{"given":"Scott W.","family":"Aesif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Christine","family":"Aubry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunhee S.","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Kloft-Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant M.","family":"Spears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia T.","family":"Greipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Sukov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja C.","family":"Roden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2017.01.028_bib1","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.athoracsur.2005.11.067","article-title":"Clinical value of the WHO classification system of thymoma","volume":"81","author":"Detterbeck","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2017.01.028_bib2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/JTO.0000000000000128","article-title":"Thymic carcinoma: a cohort study of patients from the European Society of Thoracic Surgeons database","volume":"9","author":"Ruffini","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2017.01.028_bib3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1245\/s10434-015-4825-4","article-title":"Long-term survival after surgical treatment of thymic carcinoma: a retrospective analysis from the Chinese Alliance for Research of Thymoma database","volume":"23","author":"Fu","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jtho.2017.01.028_bib4","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.athoracsur.2012.01.014","article-title":"Thymic carcinoma: outcomes after surgical resection","volume":"93","author":"Okereke","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2017.01.028_bib5","unstructured":"National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Thymomas and thymic carcinomas. https:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp. Accessed March 1, 2016."},{"key":"10.1016\/j.jtho.2017.01.028_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jtho.2016.09.118","article-title":"Radiologic response to neoadjuvant treatment predicts histologic response in\u00a0thymic epithelial tumors","volume":"12","author":"Johnson","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2017.01.028_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.athoracsur.2007.08.051","article-title":"Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors","volume":"85","author":"Wright","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2017.01.028_bib8","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ejso.2014.03.006","article-title":"Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide followed by surgery for thymic carcinoma","volume":"40","author":"Kawasaki","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jtho.2017.01.028_bib9","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/ejcts\/ezs529","article-title":"Clinicopathological features of thymic carcinomas and\u00a0the impact of histopathological agreement on prognostical studies","volume":"43","author":"Roden","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2017.01.028_bib10","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1378\/chest.128.4.2893","article-title":"Tumors of the mediastinum","volume":"128","author":"Duwe","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jtho.2017.01.028_bib11","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1038\/cddis.2012.92","article-title":"Copy number aberrations of BCL2 and CDKN2A\/B identified by array-CGH in thymic epithelial tumors","volume":"3","author":"Petrini","year":"2012","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jtho.2017.01.028_bib12","first-page":"F115","article-title":"The p16INK4a\/CDKN2A tumor suppressor and its relatives","volume":"1378","author":"Ruas","year":"1998","journal-title":"BiochimtBiophys Acta"},{"key":"10.1016\/j.jtho.2017.01.028_bib13","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/JTO.0b013e3182295745","article-title":"A\u00a0comprehensive analysis of p16 expression, gene status, and promoter hypermethylation in surgically resected non-small cell lung carcinomas","volume":"6","author":"Sterlacci","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2017.01.028_bib14","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1309\/AJCPMG0XIF7PEISO","article-title":"Improved survival in p16-positive vaginal cancers across all tumor stages but no correlation with MIB-1","volume":"142","author":"Feldbaum","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtho.2017.01.028_bib15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/PAI.0000000000000133","article-title":"The loss of p16 expression worsens the prognosis of\u00a0OSCC","volume":"23","author":"Perez-Sayans","year":"2015","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.jtho.2017.01.028_bib16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/PAS.0000000000000391","article-title":"Reproducibility of 3 histological classifications and 3 staging systems for thymic epithelial neoplasms and its effect on prognosis","volume":"39","author":"Roden","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtho.2017.01.028_bib17","series-title":"WHO Classification of Tumours of The Lung, Pleura, Thymus and Heart","year":"2015"},{"key":"10.1016\/j.jtho.2017.01.028_bib18","series-title":"WHO Classification of Tumors","first-page":"145","article-title":"Pathology and genetics of tumors of the lung, pleura, thymus and heart","author":"Travis","year":"2004"},{"key":"10.1016\/j.jtho.2017.01.028_bib19","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1097\/JTO.0000000000000290","article-title":"The IASLC\/ITMIG thymic epithelial tumors staging project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors","volume":"9","author":"Detterbeck","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2017.01.028_bib20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/1066896916648379","article-title":"Malignant melanoma of\u00a0the nail apparatus: a fluorescence in situ hybridization analysis of 7 cases","volume":"24","author":"Romano","year":"2016","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.jtho.2017.01.028_bib21","unstructured":"R Foundation for Statistical Computing. R: a language and environment for statistical computing. http:\/\/www.R-project.org\/. Accessed March 1, 2016."},{"key":"10.1016\/j.jtho.2017.01.028_bib22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature11404","article-title":"Comprehensive genomic characterization of squamous cell lung cancers","volume":"489","author":"Hammerman","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jtho.2017.01.028_bib23","first-page":"11692","article-title":"CDK4\/6 inhibitor suppresses gastric cancer with CDKN2A mutation","volume":"8","author":"Huang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jtho.2017.01.028_bib24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/PDM.0b013e31825554b2","article-title":"CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients","volume":"21","author":"Bradly","year":"2012","journal-title":"Diagn Mol Pathol B"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086417300953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086417300953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T10:26:18Z","timestamp":1536056778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086417300953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1556086417300953"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2017.01.028","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of p16INK4A Expression and Homozygous CDKN2A Deletion Are Associated with Worse Outcome and Younger Age in Thymic Carcinomas","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2017.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}